Letters
Cannabinoid hyperemesis syndrome
Authors’ reply to Braillon and Bewley, Spiller and colleagues, and Wu
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5622 (Published 23 September 2019) Cite this as: BMJ 2019;366:l5622
- Julien Vaucher, consultant and senior clinical lecturer,
- Yaniv Chocron, chief resident
- Lausanne University Hospital, 1011 Lausanne, Switzerland
- julien.vaucher{at}chuv.ch
Braillon and Bewley emphasise the importance of recognising cannabinoid hyperemesis syndrome; we are pleased that our article might help patients and physicians tackle this condition.12 Our aim was not to consider any issue related to legalisation or liberalisation of cannabis. Societal or political decisions about use of cannabis …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.